1. Home
  2. ZENV vs NVNO Comparison

ZENV vs NVNO Comparison

Compare ZENV & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zenvia Inc.

ZENV

Zenvia Inc.

HOLD

Current Price

$1.10

Market Cap

58.9M

Sector

Technology

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$0.36

Market Cap

16.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZENV
NVNO
Founded
2005
1987
Country
Brazil
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.9M
16.7M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ZENV
NVNO
Price
$1.10
$0.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
25.8K
502.6K
Earning Date
03-16-2026
10-31-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$201,426,369.00
N/A
Revenue This Year
$12.75
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
24.80
N/A
52 Week Low
$0.94
$0.30
52 Week High
$3.03
$5.62

Technical Indicators

Market Signals
Indicator
ZENV
NVNO
Relative Strength Index (RSI) 41.39 41.56
Support Level $1.05 $0.32
Resistance Level $1.15 $0.38
Average True Range (ATR) 0.08 0.04
MACD -0.01 0.02
Stochastic Oscillator 57.58 52.85

Price Performance

Historical Comparison
ZENV
NVNO

About ZENV Zenvia Inc.

Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: